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ABstRACt
This is the first case report about a transgender professional diver. The purpose of this article is to show 
the professional adaptations to help him to continue occupational dive and to raise the question of the 
impact on diving risks of hormonal treatment in this case. He was a 39-year-old man when he began his 
transition. He had worked as a diver for 9 years before his transition. When he changed to look like a wo-
man, there were a few difficulties in continuing his professional activity. The main difficulty was that he 
looked like a woman while working with men. Modesty was a crucial issue in the enterprise. There were 
other problems such as the organisation of premises, the physical workload and the interaction between 
treatments and diving. There is a lack of a law to guide the employer. French legislation does not address 
the issue of transsexuals for this profession. The medical recommendations do not specify contraindications 
or adaptations for diving safely. Because of his transition, he lost muscle mass. The occupational physician 
helped to adjust his activity: decreasing the weight of his diving suit, creating a female-like locker room 
etc. Finally, the question of the risk of decompression illness arose. Legal hormonal medication seems 
not to significantly increase the risk of decompression illness, but this diver was taking illicit treatment to 
speed up the transition. The occupational physician recommended taking the legal hormonal medication.
(Int Marit Health 2017; 68, 4: 211–214)
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INtRODUCtION
In France, the exercise of professional diving has been 
regulated by law since 1991 [1]. Divers must have a medi-
cal certificate in order to have the right to work. Hyperbaric 
exposure requires strengthened medical supervision. 
In 2016, new professional recommendations were de-
veloped [2]. A yearly medical check is still recommended 
but medical examinations are less numerous than before. 
Respiratory and cardiac explorations are performed ac-
cording to age and sex. As in most medical legislation, 
these medical recommendations are based on a binary (i.e., 
male/female) gender framework [3]. Health standards are 
adapted according to sex. Women and men do not have the 
same constraints. But which are the health standards for 
transsexual persons to be an occupational diver?
In this case-report, we describe the case of a profession-
al diver, in transition from male to female (MtF). At present, 
this person’s civil status is still officially male, whereas he 
is becoming a transgender look-like woman. In the absence 
of a specific law, and professional recommendations aside, 
how can a transgender person remain a professional diver in 
France [1, 2, 4]? According to our knowledge, there is as yet 
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no article dealing with diving in transgender people on Med-
line©. Yet, the prevalence of MtF is increasing because of 
development of new treatments (hormone, surgery etc.) [5]. 
It is estimated to be near 1 on 25,000 people [6]. The object 
of this article is therefore to discuss how a  professional 
diver can remain in professional activity during and after 
such a transition.
CAsE REPORt
He was a 41-year-old MtF transgender person. His tran-
sition began 2.5 years ago. His medical story was sport 
traumas (fracture of the clavicle, ribs fracture) and attacks of 
gout. He hadn’t received any medical treatment. He smoked 
20 cigarettes a day, and drank beer and rum occasionally 
(around 15 units of alcohol a week). His weight was 100 kg 
and his tall was 1.80 m. He had used cocaine a few years 
ago on Saturday nights before his transition. He was making 
his transition on his own, through processing purchases on 
the black market (the Boulogne Hood, Paris) thanks to his 
relationships and his involvement in the sex trade. He used 
a treatment called ‘Brazilian hormone’. It was contraceptive 
from Brazil, not allowed in France. 
On a professional level, he had been a professional diver 
for 11 years working in teams of 3 divers. The teams worked 
all over France, transporting their equipment by van. They 
slept in hotels during the week and went home on weekends. 
The main types of work were the inspection and repair of 
small port facilities: desilting, cleaning with hydraulic brushes, 
welding etc. He worked with sometimes heavy equipment, 
such as lances. The difficulty was then to get it into and out 
of the water because of the weight of the equipment. They 
also regularly checked nuclear power plants: external controls 
to collect samples, or to clean pipelines. Sometimes a few 
specially trained divers had control over the nuclear facilities 
themselves. Finally, they worked regularly in sewage treat-
ment plants and chemical plants to clean the pipes. In both 
such cases, special, completely watertight diving suits were 
used. The equipment weighed more than 50 kg.
The beginning of the transition did not raise any prob-
lems. He had mentioned it to no-one, neither his colleagues 
nor his family, because the transition was not visible and he 
did his usual job. After a while, he changed his appearance: 
gynecomastia, loss of muscles etc. He first talked to the 
doctor who followed the divers. The doctors classed him 
as female staff, and helped him to claim his new condition 
within the company. In French law, there is no class for 
transgender persons. It is why it was considered preferable 
to consider him as a woman.
This meant it became necessary to change his work 
tasks. Indeed, French legislation prohibits women from 
wearing weights of more than 25 kg. In consequence, the 
company gave him activities that were legal for women 
workers. In particular, due to the weight of the material, he 
was no longer given work in chemical factories.
For the sake of modesty, the company, on the advice 
of the occupational physician, opted for a modification of 
premises and organisation. The company set up a small 
adjoining room as a locker room for him. In terms of social 
inclusion, the intervention of the head of the company and 
the representatives of the staff must be emphasized. They 
reminded all of their employees of anti-discrimination laws 
in France. They sensitized employees in order to avoid all 
forms of discrimination: derogatory remarks, jokes, etc.
To date, this transgender person continues his profes-
sional activity with a specific medical follow-up. 
DIsCUssION
This is the first case of a transgender professional diver 
in literature. 
The hyperbaric physician has to evaluate the risk of 
decompression illness (DCI) [7]. The diver being a  man, 
one can think that risk of DCI was the same than before 
transition. But, the diver took treatment to become an MtF 
transgender person. Pathophysiological studies have shown 
that the main mechanism is the formation of bubbles [8]. 
This would be favoured by biochemical factors, such as ni-
tric oxide synthase deficiency [9]. DCI starts with formation 
and growth of inert gas bubbles, that have mechanical, 
embolic and biochemical effects. The main biological ef-
fect is an endothelial damage with platelet activation and 
deposition, inflammatory reaction with leucocyte adhesion 
and capillary leak [10]. Age, aerobic fitness and adiposity 
seem to increase the bubble formation after a dive [11]. 
The impact of other individual characteristic or medication 
is not well-known. In particular the risk associated with the 
female sex is controversial: Boussuges et al. [12] observed 
fewer circulating bubbles in premenopausal women (without 
difference with or without hormonal contraception) than in 
men and this difference disappeared in the post-menopaus-
al women (who did not take any hormonal substitution). 
This issue of DCI can be questioned because MtF trans-
gender individuals may elect to undergo hormone replace-
ment therapy (HRT) to maintain secondary female charac-
teristics. MtF transgender people who undergo HRT receive 
androgen blockers, oestrogen, and progesterone. Androgen 
blockers can be spironolactone or finasteride or dutasteride. 
Oestrogens is oestradiol, oral or sublingual, or transdermal 
or intramuscular. Progesterone can be medroxyprogester-
one acetate or micronized progesterone [13]. There are 
variations in practice according countries [14]. This HRT 
increased risk of some diseases, such as cancer [15]. For 
example, prevalence of breast neoplasm among MtF may 
be higher after HRT, probably because of exposure of exog-
enous oestrogen [16]. Another example, HRT is associated 
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with the potential for worsening cardiovascular disease risk 
factors (such as blood pressure elevation, tobacco etc.) [13]. 
There is no data about DCI among transgender persons, 
so that in this case, we considered his treatments like 
contraception treatments among women. Data from the 
literature also shows a greater prevalence of DCI among 
women [17]. Some authors have thus argued that it was 
because of menstruation and contraceptive treatment. 
Indeed, contraceptives increase the venous embolic risk 
and arterial embolic risk [18, 19]. If indeed contraceptives 
do increase risk of DCI, it would be dangerous to let him 
dive. Fortunately, the available data show no link between 
DCI and the various contraceptives [12]. The possible link 
between contraception and DCI is therefore very controver-
sial. For this diver, a priori, there was therefore no medical 
contraindication against diving. It should be borne in mind, 
however, that the embolic risk is increased among transgen-
der people [20]. The physician should be vigilant and stay 
informed of scientific advances in this regard. 
The subject of this article took oestrogens in greater 
doses. As a  result it was difficult to evaluate the risk 
of DCI. The first solution would be for the diver to take 
only treatments that are authorised for use in France. 
In addition the work tasks should be modified, reducing 
the number of dives with high DCI risk such as saturation 
dives and/or dives involving high levels of muscular ef-
fort. For example, break periods could be introduced after 
dives and mechanical handling equipment used to avoid 
strenuous physical effort during the critical moments of 
high DCI risk. It would also be appropriate to reducing 
cardiovascular risk factors such as smoking and obesity.
On one hand, this diver had actually lost muscle mass. 
On the other hand, the use of high-dose hormonal treat-
ments can have an impact on the bone health of transgen-
der people [21]. However, diving showed the same effect in 
women, due to an estrogenic stimulation [22]. It therefore 
seemed advisable to reduce the physical stress during dives. 
Other types of bone disease prevention measures should, of 
course, be taken for transgender persons, such as dietary 
supplements or drug treatments. Some studies have shown 
that this population does not have a great knowledge of 
this problem [23]. Information must therefore be provided. 
The diving profession is very largely male. Most often, 
women divers work as scientists or as veterinarians and 
animal caregivers. The physical constraints are then less 
important: lower frequency of dives, lower depths. In pro-
fessional settings, it is very rare to see women diving for 
high-level technical work, or during saturation diving. For 
this company, he was the first person considered to be 
like a woman while employed as a diver. In consequence, 
the question of decency was raised. There was no adapted 
cloakroom. The premises were modified to respect the 
decency of each diver. At the same time, one can ask the 
question of the balance of the group. The psychoanalytic 
theories on group dynamics show that, in order to defend 
themselves from fears related to occupational risks, the 
groups constitute themselves on an unconscious series 
of reciprocal tests. This is called the work defensive ide-
ology [24]. This clinical case does not make it possible to 
know how the divers will react in the long run. Will there be 
a phenomenon of rejection? Or will the group maintain its 
cohesion? The literature shows above all the improvement 
of the well-being at work of transgender people after revela-
tion of their gender. But there is no giving on other workers.
Finally, what should be the follow up for this diver? He can 
develop pathologies because of diving, but also because of 
his hormonal treatments. In France, dive monitoring mainly 
covers respiratory and cardiac functions, and ear, nose and 
throat. The recommendations for the follow-up of the trans-
gender persons are: haemoglobin, glycaemia, lipidaemia, 
levels of HRT in blood, and, if necessary, other balance, as 
prolactinaemia if symptoms appear. These blood tests should 
be performed every 3 months [13]. In consequence, this diver 
should have a medical follow-up. The maritime physician and 
the general practitioner must work together. After surgery, he 
would be at risk to develop cardiovascular diseases because 
of testosterone decrease. Transgender medicine is new, 
but there is a real thinking about guidelines [25, 26]. In 
France, transgender persons have the right to get free 
treatments. Gender dysphoria treatment costs are covered 
by the French national health insurance system. This right 
is still little known. This implies multidisciplinary care: 
follow up by an endocrinologist, a psychiatrist, sometimes 
with a  psychologist, before being entitled to a  surgical 
intervention. This may seem constraining but prevents 
transgender patients from taking potentially dangerous 
treatments. It also helps them to get out of a relational net 
that can cause them to become sex workers or to consume 
drugs, as it was the case for this diver [27]. It also makes it 
possible to detect and prevent sexually transmitted diseases 
and enables good advice to be provided on medical follow-up 
[28]. This is important as treatments are technically complex 
and can lead to important ethical questions [29].
CONCLUsIONs
To our knowledge, this is the first reported case of 
a transgender person working as a professional diver. Ad-
justments to the work post were necessary to enable this 
diver to continue professional activity. These adaptations 
were facilitated by the intervention of the occupational 
physician within the company, as well as by the good will of 
the management. Adaptations took into account changes 
in physical abilities, the need for medical follow-up, as well 
as questions of physical change and modesty.
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